Medicare Enrolled
Dr. Harry Hughes, M.D.
Neurology · Augusta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hughes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hughes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hughes
Dr. Harry Hughes is a neurology specialist in Augusta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hughes performed 1,178 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hughes received a total of $20,683 from 78 pharmaceutical and/or device companies across 1183 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hughes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 26% volume in GA
$20,683 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,178
Medicare services
Top 26% in GA for neurology
Not available
Unique patients (not deduplicated)
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
692 | $83 | $200 |
| New patient office visit, complex (60-74 min) | 162 | $143 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
91 | $124 | $280 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
54 | $64 | $282 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
44 | $110 | $640 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
44 | $185 | $880 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
44 | $277 | $750 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
18 | $85 | $840 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
15 | $133 | $1,400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $52 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$20,683
Total received (2018-2024)
Avg $2,955/year across 7 years
Top 16% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
1,183
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,467
2023
$4,002
2022
$3,577
2021
$2,601
2020
$2,220
2019
$2,650
2018
$2,166
Payments by company (2024)
ABBVIE INC.
$404
PFIZER INC.
$294
ARGENX US, INC.
$266
Neurocrine Biosciences, Inc.
$263
MDD US Operations, LLC
$252
Novartis Pharmaceuticals Corporation
$171
Teva Pharmaceuticals USA, Inc.
$150
Eisai Inc.
$143
Lilly USA, LLC
$137
Takeda Pharmaceuticals U.S.A., Inc.
$132
UCB, Inc.
$119
BANNER LIFE SCIENCES, LLC
$117
EMD Serono, Inc.
$113
SK Life Science, Inc.
$101
Neurelis, Inc.
$91
Genentech USA, Inc.
$84
Otsuka America Pharmaceutical, Inc.
$68
Alexion Pharmaceuticals, Inc.
$66
Biogen, Inc.
$58
SCILEX PHARMACEUTICALS INC.
$46
AstraZeneca Pharmaceuticals LP
$44
Grifols USA, LLC
$44
Mallinckrodt Hospital Products Inc.
$43
TG Therapeutics, Inc.
$41
Acorda Therapeutics, Inc
$40
Lundbeck LLC
$28
Janssen Pharmaceuticals, Inc
$27
Merz Pharmaceuticals, LLC
$27
Kyowa Kirin, Inc.
$26
Kedrion Biopharma, Inc.
$19
Celgene Corporation
$18
LivaNova USA, Inc.
$18
Boston Scientific Corporation
$16
Top 3 companies account for 27.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,490
ABBVIE INC.
$1,488
EMD Serono, Inc.
$1,172
Novartis Pharmaceuticals Corporation
$1,121
Amgen Inc.
$814
GENZYME CORPORATION
$801
Biogen, Inc.
$732
ARGENX US, INC.
$705
Neurocrine Biosciences, Inc.
$633
Eisai Inc.
$593
UCB, Inc.
$582
Genentech USA, Inc.
$561
MDD US Operations, LLC
$551
PFIZER INC.
$535
Lundbeck LLC
$509
SK Life Science, Inc.
$499
Supernus Pharmaceuticals, Inc.
$490
Adamas Pharmaceuticals, Inc.
$441
AbbVie Inc.
$430
Allergan, Inc.
$395
Neurelis, Inc.
$361
Amneal Pharmaceuticals LLC
$333
IMPEL PHARMACEUTICALS INC.
$300
EISAI INC.
$266
Upsher-Smith Laboratories LLC
$265
Alexion Pharmaceuticals, Inc.
$265
Lilly USA, LLC
$259
BANNER LIFE SCIENCES, LLC
$241
Otsuka America Pharmaceutical, Inc.
$229
Kyowa Kirin, Inc.
$217
Mallinckrodt Hospital Products Inc.
$197
Biohaven Pharmaceutical Holding Company Ltd.
$195
Merz Pharmaceuticals, LLC
$190
Avanir Pharmaceuticals, Inc.
$188
Janssen Pharmaceuticals, Inc
$165
GE HEALTHCARE
$150
Takeda Pharmaceuticals U.S.A., Inc.
$150
Sunovion Pharmaceuticals Inc.
$149
Allergan Inc.
$139
Grifols USA, LLC
$124
Acorda Therapeutics, Inc
$113
US WorldMeds, LLC
$104
Bayer HealthCare Pharmaceuticals Inc.
$102
UPSHER-SMITH LABORATORIES LLC
$100
ACADIA Pharmaceuticals Inc
$93
Avion Pharmaceuticals
$89
MITSUBISHI TANABE PHARMA AMERICA, INC.
$84
Impax Laboratories, Inc.
$73
LivaNova USA, Inc.
$68
Biohaven Pharmaceuticals, Inc.
$66
AstraZeneca Pharmaceuticals LP
$63
Scilex Pharmaceuticals Inc.
$57
Celgene Corporation
$50
Catalyst Pharmaceuticals, Inc.
$49
Mallinckrodt LLC
$48
SCILEX PHARMACEUTICALS INC.
$46
ASSERTIO THERAPEUTICS, Inc.
$41
TG Therapeutics, Inc.
$41
E.R. Squibb & Sons, L.L.C.
$34
Stryker Corporation
$34
Horizon Therapeutics plc
$33
Boston Scientific Corporation
$32
Amylyx Pharmaceuticals, Inc.
$32
Egalet US Inc
$30
SANOFI-AVENTIS U.S. LLC
$27
Cala Health, Inc.
$26
TG THERAPEUTICS, INC.
$22
Mallinckrodt Enterprises LLC
$22
Bausch Health US, LLC
$22
BOSTON SCIENTIFIC CORPORATION
$20
Abbott Laboratories
$19
Kedrion Biopharma, Inc.
$19
Harmony Biosciences LLC
$19
Merz North America, Inc.
$17
Averitas Pharma Inc.
$17
Alnylam Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$14
Zyla Life Sciences, Inc.
$13
Top 3 companies account for 20.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dhivy · EMGALITY · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINZESS · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · POMPE - DISEASE · PROCLAIM · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · REYVOW · RYTARY · Rebif · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · SPRAVATO · SPRIX · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · WaveWriter Alpha Prime 16 · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
83
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hughes is a clinical cardiology specialist, with above-average Medicare volume (top 26% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hughes experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hughes performed 692 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hughes receive payments from pharmaceutical companies?
Yes. Dr. Hughes received a total of $20,683 from 78 companies across 1,183 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hughes's costs compare to other neurologists in Augusta?
Dr. Hughes's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hughes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Augusta
Browse neurologists in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology